<i>In silico</i> drug discovery pipelines targeting antibiotic resistance: from genomes to leads. [PDF]
Gupta R +7 more
europepmc +1 more source
Nanotechnology-Driven Strategies to Combat Antimicrobial Resistance in the One Health Era. [PDF]
Al-Shaebi Z, Akdeniz M, Aydin O.
europepmc +1 more source
Phage Therapy Enhanced by Using Engineered Bacteriophages: A Powerful Antibacterial Tool to Address the Dilemma Posed by Multidrug-Resistant Bacterial Infections. [PDF]
Wang X, Zhou H, Lim TS, Węgrzyn G.
europepmc +1 more source
Antibacterial Immunotherapy: Mechanistic Insights, Emerging Therapeutic Strategies, and Clinical Translation. [PDF]
Al-Azzani H +6 more
europepmc +1 more source
Research Status and Prospects of <i>Helicobacter pylori</i>-associated gastritis: From Mechanisms to Traditional Chinese Medicine Treatment. [PDF]
Fan Z, Jin Z, Liu C, Hu R, Li W.
europepmc +1 more source
<i>Shigella</i> infections in the era of antimicrobial resistance: Insights into cephalosporin use. [PDF]
Wang W +5 more
europepmc +1 more source
Antimicrobial resistance surveillance of clinical bacterial isolates at Maryamana private hospital, Erbil-Iraq (2023-2025): antibiogram data and multidrug-resistant (MDR)/extensively drug-resistant (XDR)/pandrug-resistant (PDR) classification. [PDF]
Hanna Aka ST.
europepmc +1 more source
Nanotechnology-Enabled Strategies to Overcome Antibiotic Resistance in Respiratory Infections: Mechanisms, Platforms, and Translational Challenges. [PDF]
Muteeb G, Siraj RA.
europepmc +1 more source
Addressing antimicrobial resistance: Current challenges, emerging strategies, and an AI-powered, community-driven approach. [PDF]
Wang P +13 more
europepmc +1 more source
Antimicrobial resistance within the one health lens: global drivers, mechanisms and public health policy gaps in low resource settings. [PDF]
Mugenyi N +3 more
europepmc +1 more source

